Sponsor:
Novartis Pharmaceuticals
Code:
NCT05739383
Conditions
Primary Prevention of Atherosclerotic Cardiovascular Disease
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
Placebo in 1.5ml
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations